4 Results for "

corticobasal degeneration

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "corticobasal degeneration" in MCE Product Catalog:

Cat. No.: HY-P99648
CAS No.: 1788032-39-2
Synonyms: BMS-986168; IPN007; BIIB092

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Gosuranemab (BMS-986168; IPN007; BIIB092) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab neutralizes the extracellular tau protein, inhibiting the spread and aggregation of pathological tau protein. Gosuranemab can be used for the research of progressive supranuclear palsy and early Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-173291
CAS No.: 3063166-64-0
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Tau ligand-1 (Compound 75) is a ligand for aggregated tau protein that can penetrate the blood-brain barrier . In tissues from patients with Alzheimer's disease, progressive supranuclear palsy, corticobasal degeneration, and Pick's disease, Tau ligand-1 exhibits high affinity for aggregated tau protein, with equilibrium dissociation constant (KD) values ranging from 1 to 3.8 nM . Tau ligand-1 can serve as a potential positron emission tomography (PET) tracer and holds promise for application in positron emission tomography imaging studies of tau-related diseases in the central nervous system .
loading...
    loading...
Cat. No.: HY-185357
CAS No.: 3083792-74-6
Target:  

Tau Protein

Research Areas:  

Neurological Disease

TAU-IN-6 (Compound 13) is a Tau protein misfolding and aggregation inhibitor. TAU-IN-6 inhibits stress granules composed of tau and TIA1. TAU-IN-6 is applicable for Alzheimer's disease research .
loading...
    loading...
Cat. No.: HY-187114
CAS No.: 1841078-84-9
3-(1H-Pyrrolo[2,3-c]pyridin-1-yl)-7-isoquinolinol is a pyrrolopyridine compound that binds to tau aggregates and β-amyloid aggregates. 3-(1H-Pyrrolo[2,3-c]pyridin-1-yl)-7-isoquinolinol serves as a positron emission tomography (PET) tracer for research related to Alzheimer's disease and other neurodegenerative diseases characterized by tau pathology .
loading...
    loading...